Nura A Almansour, Seham S Alsalamah, Razan S Alsubaie, Nada N Alshathri, Yasmeen A Alhedyan, Faisal Y Althekair's
{"title":"Association between migraine severity and sleep quality: a nationwide cross-sectional study.","authors":"Nura A Almansour, Seham S Alsalamah, Razan S Alsubaie, Nada N Alshathri, Yasmeen A Alhedyan, Faisal Y Althekair's","doi":"10.3389/fneur.2025.1529213","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Migraine is a primary headache disorder that affects more than 1 billion individuals globally and imposes a significant disability burden on society. Although migraine patients commonly experience poor sleep quality, the relationship between migraine and sleep is not yet fully understood. This study therefore aimed to determine the association between sleep quality and migraine severity.</p><p><strong>Methods: </strong>A comparative cross-sectional study was conducted with 1,399 participants across all regions of Saudi Arabia from August to October 2023 using standardized questionnaires. Participants were categorized into patients with migraine and non-migraine patients, according to the International Headache Society (IHS) criteria. This study utilized The Migraine Disability Assessment Scale (MIDAS) and Pittsburgh Sleep Quality Index (PSQI) to evaluate migraine severity and sleep quality, respectively.</p><p><strong>Results: </strong>The prevalence of migraine was 25%, while poor sleep quality was evident in 42.4% of the patients. No significant difference in PSQI scores was observed between patients with migraine and non-migraine patients (<i>p</i> = 0.821). Migraine patients with poor sleep quality showed significantly higher MIDAS scores than those with good sleep quality (10.37 vs. 6.58; <i>p</i> = 0.002), while patients with migraine with higher levels of disability had higher PSQI scores than those with lower levels of disability, although the difference was not statistically significance (7.61 vs. 6.81, <i>p</i> = 0.053). A significant positive correlation was found between the PSQI and MIDAS scores (<i>r</i> = 0.179, <i>p</i> < 0.001). MIDAS was also significantly positively correlated with the following PSQI components: subjective sleep quality (<i>p</i> = 0.047), sleep latency (<i>p</i> < 0.001), sleep disturbance (<i>p</i> < 0.001), and daytime dysfunction (<i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>These findings suggest a notable correlation between poor sleep quality and increased migraine severity, emphasizing the importance of addressing sleep disturbance as a potential strategy to mitigate migraine severity and improve patient outcomes.</p>","PeriodicalId":12575,"journal":{"name":"Frontiers in Neurology","volume":"16 ","pages":"1529213"},"PeriodicalIF":2.8000,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11827218/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fneur.2025.1529213","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Migraine is a primary headache disorder that affects more than 1 billion individuals globally and imposes a significant disability burden on society. Although migraine patients commonly experience poor sleep quality, the relationship between migraine and sleep is not yet fully understood. This study therefore aimed to determine the association between sleep quality and migraine severity.
Methods: A comparative cross-sectional study was conducted with 1,399 participants across all regions of Saudi Arabia from August to October 2023 using standardized questionnaires. Participants were categorized into patients with migraine and non-migraine patients, according to the International Headache Society (IHS) criteria. This study utilized The Migraine Disability Assessment Scale (MIDAS) and Pittsburgh Sleep Quality Index (PSQI) to evaluate migraine severity and sleep quality, respectively.
Results: The prevalence of migraine was 25%, while poor sleep quality was evident in 42.4% of the patients. No significant difference in PSQI scores was observed between patients with migraine and non-migraine patients (p = 0.821). Migraine patients with poor sleep quality showed significantly higher MIDAS scores than those with good sleep quality (10.37 vs. 6.58; p = 0.002), while patients with migraine with higher levels of disability had higher PSQI scores than those with lower levels of disability, although the difference was not statistically significance (7.61 vs. 6.81, p = 0.053). A significant positive correlation was found between the PSQI and MIDAS scores (r = 0.179, p < 0.001). MIDAS was also significantly positively correlated with the following PSQI components: subjective sleep quality (p = 0.047), sleep latency (p < 0.001), sleep disturbance (p < 0.001), and daytime dysfunction (p < 0.001).
Conclusion: These findings suggest a notable correlation between poor sleep quality and increased migraine severity, emphasizing the importance of addressing sleep disturbance as a potential strategy to mitigate migraine severity and improve patient outcomes.
背景:偏头痛是一种原发性头痛疾病,影响全球超过10亿人,并对社会造成严重的残疾负担。虽然偏头痛患者通常睡眠质量差,但偏头痛和睡眠之间的关系尚未完全了解。因此,这项研究旨在确定睡眠质量和偏头痛严重程度之间的关系。方法:2023年8月至10月,采用标准化问卷对沙特阿拉伯所有地区的1399名参与者进行了一项比较横断面研究。根据国际头痛学会(IHS)的标准,参与者被分为偏头痛患者和非偏头痛患者。本研究采用偏头痛残疾评估量表(MIDAS)和匹兹堡睡眠质量指数(PSQI)分别评估偏头痛的严重程度和睡眠质量。结果:偏头痛患病率为25%,睡眠质量差的占42.4%。偏头痛患者与非偏头痛患者的PSQI评分差异无统计学意义(p = 0.821)。睡眠质量差的偏头痛患者的MIDAS评分显著高于睡眠质量好的偏头痛患者(10.37 vs. 6.58;p = 0.002),而重度残疾偏头痛患者的PSQI评分高于轻度残疾偏头痛患者,但差异无统计学意义(7.61 vs. 6.81, p = 0.053)。PSQI与MIDAS评分(r = 0.179,p p = 0.047)、睡眠潜伏期(p p p )之间存在显著正相关。结论:这些发现提示睡眠质量差与偏头痛严重程度增加之间存在显著相关性,强调了解决睡眠障碍作为减轻偏头痛严重程度和改善患者预后的潜在策略的重要性。
期刊介绍:
The section Stroke aims to quickly and accurately publish important experimental, translational and clinical studies, and reviews that contribute to the knowledge of stroke, its causes, manifestations, diagnosis, and management.